1 Study Coverage
    1.1 Monoclonal Antibodies Product Introduction
    1.2 Market by Type
        1.2.1 Global Monoclonal Antibodies Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Erythropoietin (EPO)
        1.2.3 Human Growth Hormone (HGH)
        1.2.4 Granulocyte- Colony Stimulating Factor (G-CSF)
        1.2.5 Monoclonal Antibody (mAb)
        1.2.6 Insulin
        1.2.7 Interferon (IFN)
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Monoclonal Antibodies Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Anti-Cancer
        1.3.3 Anti-Inflammatory/Autoimmune
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Monoclonal Antibodies Sales Estimates and Forecasts 2017-2028
    2.2 Global Monoclonal Antibodies Revenue Estimates and Forecasts 2017-2028
    2.3 Global Monoclonal Antibodies Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Monoclonal Antibodies Sales by Region
        2.4.1 Global Monoclonal Antibodies Sales by Region (2017-2022)
        2.4.2 Global Sales Monoclonal Antibodies by Region (2023-2028)
    2.5 Global Monoclonal Antibodies Revenue by Region
        2.5.1 Global Monoclonal Antibodies Revenue by Region (2017-2022)
        2.5.2 Global Monoclonal Antibodies Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Monoclonal Antibodies Sales by Manufacturers
        3.1.1 Global Top Monoclonal Antibodies Manufacturers by Sales (2017-2022)
        3.1.2 Global Monoclonal Antibodies Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Monoclonal Antibodies in 2021
    3.2 Global Monoclonal Antibodies Revenue by Manufacturers
        3.2.1 Global Monoclonal Antibodies Revenue by Manufacturers (2017-2022)
        3.2.2 Global Monoclonal Antibodies Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Monoclonal Antibodies Revenue in 2021
    3.3 Global Monoclonal Antibodies Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Monoclonal Antibodies Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Monoclonal Antibodies Sales by Type
        4.1.1 Global Monoclonal Antibodies Historical Sales by Type (2017-2022)
        4.1.2 Global Monoclonal Antibodies Forecasted Sales by Type (2023-2028)
        4.1.3 Global Monoclonal Antibodies Sales Market Share by Type (2017-2028)
    4.2 Global Monoclonal Antibodies Revenue by Type
        4.2.1 Global Monoclonal Antibodies Historical Revenue by Type (2017-2022)
        4.2.2 Global Monoclonal Antibodies Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Monoclonal Antibodies Revenue Market Share by Type (2017-2028)
    4.3 Global Monoclonal Antibodies Price by Type
        4.3.1 Global Monoclonal Antibodies Price by Type (2017-2022)
        4.3.2 Global Monoclonal Antibodies Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Monoclonal Antibodies Sales by Application
        5.1.1 Global Monoclonal Antibodies Historical Sales by Application (2017-2022)
        5.1.2 Global Monoclonal Antibodies Forecasted Sales by Application (2023-2028)
        5.1.3 Global Monoclonal Antibodies Sales Market Share by Application (2017-2028)
    5.2 Global Monoclonal Antibodies Revenue by Application
        5.2.1 Global Monoclonal Antibodies Historical Revenue by Application (2017-2022)
        5.2.2 Global Monoclonal Antibodies Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Monoclonal Antibodies Revenue Market Share by Application (2017-2028)
    5.3 Global Monoclonal Antibodies Price by Application
        5.3.1 Global Monoclonal Antibodies Price by Application (2017-2022)
        5.3.2 Global Monoclonal Antibodies Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Monoclonal Antibodies Market Size by Type
        6.1.1 North America Monoclonal Antibodies Sales by Type (2017-2028)
        6.1.2 North America Monoclonal Antibodies Revenue by Type (2017-2028)
    6.2 North America Monoclonal Antibodies Market Size by Application
        6.2.1 North America Monoclonal Antibodies Sales by Application (2017-2028)
        6.2.2 North America Monoclonal Antibodies Revenue by Application (2017-2028)
    6.3 North America Monoclonal Antibodies Market Size by Country
        6.3.1 North America Monoclonal Antibodies Sales by Country (2017-2028)
        6.3.2 North America Monoclonal Antibodies Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Monoclonal Antibodies Market Size by Type
        7.1.1 Europe Monoclonal Antibodies Sales by Type (2017-2028)
        7.1.2 Europe Monoclonal Antibodies Revenue by Type (2017-2028)
    7.2 Europe Monoclonal Antibodies Market Size by Application
        7.2.1 Europe Monoclonal Antibodies Sales by Application (2017-2028)
        7.2.2 Europe Monoclonal Antibodies Revenue by Application (2017-2028)
    7.3 Europe Monoclonal Antibodies Market Size by Country
        7.3.1 Europe Monoclonal Antibodies Sales by Country (2017-2028)
        7.3.2 Europe Monoclonal Antibodies Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Monoclonal Antibodies Market Size by Type
        8.1.1 Asia Pacific Monoclonal Antibodies Sales by Type (2017-2028)
        8.1.2 Asia Pacific Monoclonal Antibodies Revenue by Type (2017-2028)
    8.2 Asia Pacific Monoclonal Antibodies Market Size by Application
        8.2.1 Asia Pacific Monoclonal Antibodies Sales by Application (2017-2028)
        8.2.2 Asia Pacific Monoclonal Antibodies Revenue by Application (2017-2028)
    8.3 Asia Pacific Monoclonal Antibodies Market Size by Region
        8.3.1 Asia Pacific Monoclonal Antibodies Sales by Region (2017-2028)
        8.3.2 Asia Pacific Monoclonal Antibodies Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Monoclonal Antibodies Market Size by Type
        9.1.1 Latin America Monoclonal Antibodies Sales by Type (2017-2028)
        9.1.2 Latin America Monoclonal Antibodies Revenue by Type (2017-2028)
    9.2 Latin America Monoclonal Antibodies Market Size by Application
        9.2.1 Latin America Monoclonal Antibodies Sales by Application (2017-2028)
        9.2.2 Latin America Monoclonal Antibodies Revenue by Application (2017-2028)
    9.3 Latin America Monoclonal Antibodies Market Size by Country
        9.3.1 Latin America Monoclonal Antibodies Sales by Country (2017-2028)
        9.3.2 Latin America Monoclonal Antibodies Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Monoclonal Antibodies Market Size by Type
        10.1.1 Middle East and Africa Monoclonal Antibodies Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Monoclonal Antibodies Revenue by Type (2017-2028)
    10.2 Middle East and Africa Monoclonal Antibodies Market Size by Application
        10.2.1 Middle East and Africa Monoclonal Antibodies Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Monoclonal Antibodies Revenue by Application (2017-2028)
    10.3 Middle East and Africa Monoclonal Antibodies Market Size by Country
        10.3.1 Middle East and Africa Monoclonal Antibodies Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Monoclonal Antibodies Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Biocon
        11.1.1 Biocon Corporation Information
        11.1.2 Biocon Overview
        11.1.3 Biocon Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Biocon Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Biocon Recent Developments
    11.2 Celltrion
        11.2.1 Celltrion Corporation Information
        11.2.2 Celltrion Overview
        11.2.3 Celltrion Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Celltrion Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Celltrion Recent Developments
    11.3 Dr. Reddy's Laboratories
        11.3.1 Dr. Reddy's Laboratories Corporation Information
        11.3.2 Dr. Reddy's Laboratories Overview
        11.3.3 Dr. Reddy's Laboratories Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Dr. Reddy's Laboratories Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Dr. Reddy's Laboratories Recent Developments
    11.4 Hospira
        11.4.1 Hospira Corporation Information
        11.4.2 Hospira Overview
        11.4.3 Hospira Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Hospira Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Hospira Recent Developments
    11.5 3SBio
        11.5.1 3SBio Corporation Information
        11.5.2 3SBio Overview
        11.5.3 3SBio Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 3SBio Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 3SBio Recent Developments
    11.6 Accord Healthcare
        11.6.1 Accord Healthcare Corporation Information
        11.6.2 Accord Healthcare Overview
        11.6.3 Accord Healthcare Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Accord Healthcare Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Accord Healthcare Recent Developments
    11.7 AET Biotech
        11.7.1 AET Biotech Corporation Information
        11.7.2 AET Biotech Overview
        11.7.3 AET Biotech Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 AET Biotech Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 AET Biotech Recent Developments
    11.8 Allergan
        11.8.1 Allergan Corporation Information
        11.8.2 Allergan Overview
        11.8.3 Allergan Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Allergan Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Allergan Recent Developments
    11.9 Amega Biotech
        11.9.1 Amega Biotech Corporation Information
        11.9.2 Amega Biotech Overview
        11.9.3 Amega Biotech Monoclonal Antibodies Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Amega Biotech Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Amega Biotech Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Monoclonal Antibodies Industry Chain Analysis
    12.2 Monoclonal Antibodies Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Monoclonal Antibodies Production Mode & Process
    12.4 Monoclonal Antibodies Sales and Marketing
        12.4.1 Monoclonal Antibodies Sales Channels
        12.4.2 Monoclonal Antibodies Distributors
    12.5 Monoclonal Antibodies Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Monoclonal Antibodies Industry Trends
    13.2 Monoclonal Antibodies Market Drivers
    13.3 Monoclonal Antibodies Market Challenges
    13.4 Monoclonal Antibodies Market Restraints
14 Key Findings in The Global Monoclonal Antibodies Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Monoclonal Antibodies Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Erythropoietin (EPO)
    Table 3. Major Manufacturers of Human Growth Hormone (HGH)
    Table 4. Major Manufacturers of Granulocyte- Colony Stimulating Factor (G-CSF)
    Table 5. Major Manufacturers of Monoclonal Antibody (mAb)
    Table 6. Major Manufacturers of Insulin
    Table 7. Major Manufacturers of Interferon (IFN)
    Table 8. Major Manufacturers of Others
    Table 9. Global Monoclonal Antibodies Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 10. Global Monoclonal Antibodies Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 11. Global Monoclonal Antibodies Sales by Region (2017-2022) & (Kg)
    Table 12. Global Monoclonal Antibodies Sales Market Share by Region (2017-2022)
    Table 13. Global Monoclonal Antibodies Sales by Region (2023-2028) & (Kg)
    Table 14. Global Monoclonal Antibodies Sales Market Share by Region (2023-2028)
    Table 15. Global Monoclonal Antibodies Revenue by Region (2017-2022) & (US$ Million)
    Table 16. Global Monoclonal Antibodies Revenue Market Share by Region (2017-2022)
    Table 17. Global Monoclonal Antibodies Revenue by Region (2023-2028) & (US$ Million)
    Table 18. Global Monoclonal Antibodies Revenue Market Share by Region (2023-2028)
    Table 19. Global Monoclonal Antibodies Sales by Manufacturers (2017-2022) & (Kg)
    Table 20. Global Monoclonal Antibodies Sales Share by Manufacturers (2017-2022)
    Table 21. Global Monoclonal Antibodies Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 22. Global Monoclonal Antibodies Revenue Share by Manufacturers (2017-2022)
    Table 23. Monoclonal Antibodies Price by Manufacturers (2017-2022) &(USD/Kg)
    Table 24. Global Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 25. Global Monoclonal Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibodies as of 2021)
    Table 26. Monoclonal Antibodies Manufacturing Base Distribution and Headquarters
    Table 27. Manufacturers Monoclonal Antibodies Product Offered
    Table 28. Date of Manufacturers Enter into Monoclonal Antibodies Market
    Table 29. Mergers & Acquisitions, Expansion Plans
    Table 30. Global Monoclonal Antibodies Sales by Type (2017-2022) & (Kg)
    Table 31. Global Monoclonal Antibodies Sales by Type (2023-2028) & (Kg)
    Table 32. Global Monoclonal Antibodies Sales Share by Type (2017-2022)
    Table 33. Global Monoclonal Antibodies Sales Share by Type (2023-2028)
    Table 34. Global Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
    Table 35. Global Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
    Table 36. Global Monoclonal Antibodies Revenue Share by Type (2017-2022)
    Table 37. Global Monoclonal Antibodies Revenue Share by Type (2023-2028)
    Table 38. Monoclonal Antibodies Price by Type (2017-2022) & (USD/Kg)
    Table 39. Global Monoclonal Antibodies Price Forecast by Type (2023-2028) & (USD/Kg)
    Table 40. Global Monoclonal Antibodies Sales by Application (2017-2022) & (Kg)
    Table 41. Global Monoclonal Antibodies Sales by Application (2023-2028) & (Kg)
    Table 42. Global Monoclonal Antibodies Sales Share by Application (2017-2022)
    Table 43. Global Monoclonal Antibodies Sales Share by Application (2023-2028)
    Table 44. Global Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
    Table 45. Global Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
    Table 46. Global Monoclonal Antibodies Revenue Share by Application (2017-2022)
    Table 47. Global Monoclonal Antibodies Revenue Share by Application (2023-2028)
    Table 48. Monoclonal Antibodies Price by Application (2017-2022) & (USD/Kg)
    Table 49. Global Monoclonal Antibodies Price Forecast by Application (2023-2028) & (USD/Kg)
    Table 50. North America Monoclonal Antibodies Sales by Type (2017-2022) & (Kg)
    Table 51. North America Monoclonal Antibodies Sales by Type (2023-2028) & (Kg)
    Table 52. North America Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
    Table 53. North America Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
    Table 54. North America Monoclonal Antibodies Sales by Application (2017-2022) & (Kg)
    Table 55. North America Monoclonal Antibodies Sales by Application (2023-2028) & (Kg)
    Table 56. North America Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
    Table 57. North America Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
    Table 58. North America Monoclonal Antibodies Sales by Country (2017-2022) & (Kg)
    Table 59. North America Monoclonal Antibodies Sales by Country (2023-2028) & (Kg)
    Table 60. North America Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
    Table 61. North America Monoclonal Antibodies Revenue by Country (2023-2028) & (US$ Million)
    Table 62. Europe Monoclonal Antibodies Sales by Type (2017-2022) & (Kg)
    Table 63. Europe Monoclonal Antibodies Sales by Type (2023-2028) & (Kg)
    Table 64. Europe Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
    Table 65. Europe Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
    Table 66. Europe Monoclonal Antibodies Sales by Application (2017-2022) & (Kg)
    Table 67. Europe Monoclonal Antibodies Sales by Application (2023-2028) & (Kg)
    Table 68. Europe Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
    Table 69. Europe Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
    Table 70. Europe Monoclonal Antibodies Sales by Country (2017-2022) & (Kg)
    Table 71. Europe Monoclonal Antibodies Sales by Country (2023-2028) & (Kg)
    Table 72. Europe Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
    Table 73. Europe Monoclonal Antibodies Revenue by Country (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Monoclonal Antibodies Sales by Type (2017-2022) & (Kg)
    Table 75. Asia Pacific Monoclonal Antibodies Sales by Type (2023-2028) & (Kg)
    Table 76. Asia Pacific Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Monoclonal Antibodies Sales by Application (2017-2022) & (Kg)
    Table 79. Asia Pacific Monoclonal Antibodies Sales by Application (2023-2028) & (Kg)
    Table 80. Asia Pacific Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
    Table 82. Asia Pacific Monoclonal Antibodies Sales by Region (2017-2022) & (Kg)
    Table 83. Asia Pacific Monoclonal Antibodies Sales by Region (2023-2028) & (Kg)
    Table 84. Asia Pacific Monoclonal Antibodies Revenue by Region (2017-2022) & (US$ Million)
    Table 85. Asia Pacific Monoclonal Antibodies Revenue by Region (2023-2028) & (US$ Million)
    Table 86. Latin America Monoclonal Antibodies Sales by Type (2017-2022) & (Kg)
    Table 87. Latin America Monoclonal Antibodies Sales by Type (2023-2028) & (Kg)
    Table 88. Latin America Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
    Table 89. Latin America Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
    Table 90. Latin America Monoclonal Antibodies Sales by Application (2017-2022) & (Kg)
    Table 91. Latin America Monoclonal Antibodies Sales by Application (2023-2028) & (Kg)
    Table 92. Latin America Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
    Table 93. Latin America Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
    Table 94. Latin America Monoclonal Antibodies Sales by Country (2017-2022) & (Kg)
    Table 95. Latin America Monoclonal Antibodies Sales by Country (2023-2028) & (Kg)
    Table 96. Latin America Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
    Table 97. Latin America Monoclonal Antibodies Revenue by Country (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Monoclonal Antibodies Sales by Type (2017-2022) & (Kg)
    Table 99. Middle East and Africa Monoclonal Antibodies Sales by Type (2023-2028) & (Kg)
    Table 100. Middle East and Africa Monoclonal Antibodies Revenue by Type (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Monoclonal Antibodies Revenue by Type (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Monoclonal Antibodies Sales by Application (2017-2022) & (Kg)
    Table 103. Middle East and Africa Monoclonal Antibodies Sales by Application (2023-2028) & (Kg)
    Table 104. Middle East and Africa Monoclonal Antibodies Revenue by Application (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Monoclonal Antibodies Revenue by Application (2023-2028) & (US$ Million)
    Table 106. Middle East and Africa Monoclonal Antibodies Sales by Country (2017-2022) & (Kg)
    Table 107. Middle East and Africa Monoclonal Antibodies Sales by Country (2023-2028) & (Kg)
    Table 108. Middle East and Africa Monoclonal Antibodies Revenue by Country (2017-2022) & (US$ Million)
    Table 109. Middle East and Africa Monoclonal Antibodies Revenue by Country (2023-2028) & (US$ Million)
    Table 110. Biocon Corporation Information
    Table 111. Biocon Description and Major Businesses
    Table 112. Biocon Monoclonal Antibodies Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 113. Biocon Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Biocon Recent Developments
    Table 115. Celltrion Corporation Information
    Table 116. Celltrion Description and Major Businesses
    Table 117. Celltrion Monoclonal Antibodies Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 118. Celltrion Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Celltrion Recent Developments
    Table 120. Dr. Reddy's Laboratories Corporation Information
    Table 121. Dr. Reddy's Laboratories Description and Major Businesses
    Table 122. Dr. Reddy's Laboratories Monoclonal Antibodies Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 123. Dr. Reddy's Laboratories Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Dr. Reddy's Laboratories Recent Developments
    Table 125. Hospira Corporation Information
    Table 126. Hospira Description and Major Businesses
    Table 127. Hospira Monoclonal Antibodies Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 128. Hospira Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Hospira Recent Developments
    Table 130. 3SBio Corporation Information
    Table 131. 3SBio Description and Major Businesses
    Table 132. 3SBio Monoclonal Antibodies Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 133. 3SBio Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. 3SBio Recent Developments
    Table 135. Accord Healthcare Corporation Information
    Table 136. Accord Healthcare Description and Major Businesses
    Table 137. Accord Healthcare Monoclonal Antibodies Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 138. Accord Healthcare Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Accord Healthcare Recent Developments
    Table 140. AET Biotech Corporation Information
    Table 141. AET Biotech Description and Major Businesses
    Table 142. AET Biotech Monoclonal Antibodies Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 143. AET Biotech Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. AET Biotech Recent Developments
    Table 145. Allergan Corporation Information
    Table 146. Allergan Description and Major Businesses
    Table 147. Allergan Monoclonal Antibodies Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 148. Allergan Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Allergan Recent Developments
    Table 150. Amega Biotech Corporation Information
    Table 151. Amega Biotech Description and Major Businesses
    Table 152. Amega Biotech Monoclonal Antibodies Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 153. Amega Biotech Monoclonal Antibodies Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Amega Biotech Recent Developments
    Table 155. Key Raw Materials Lists
    Table 156. Raw Materials Key Suppliers Lists
    Table 157. Monoclonal Antibodies Distributors List
    Table 158. Monoclonal Antibodies Customers List
    Table 159. Monoclonal Antibodies Market Trends
    Table 160. Monoclonal Antibodies Market Drivers
    Table 161. Monoclonal Antibodies Market Challenges
    Table 162. Monoclonal Antibodies Market Restraints
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Monoclonal Antibodies Product Picture
    Figure 3. Global Monoclonal Antibodies Market Share by Type in 2021 & 2028
    Figure 3. Erythropoietin (EPO) Product Picture
    Figure 4. Human Growth Hormone (HGH) Product Picture
    Figure 5. Granulocyte- Colony Stimulating Factor (G-CSF) Product Picture
    Figure 6. Monoclonal Antibody (mAb) Product Picture
    Figure 7. Insulin Product Picture
    Figure 8. Interferon (IFN) Product Picture
    Figure 9. Others Product Picture
    Figure 10. Global Monoclonal Antibodies Market Share by Application in 2021 & 2028
    Figure 11. Anti-Cancer
    Figure 12. Anti-Inflammatory/Autoimmune
    Figure 13. Monoclonal Antibodies Report Years Considered
    Figure 14. Global Monoclonal Antibodies Sales 2017-2028 (Kg)
    Figure 15. Global Monoclonal Antibodies Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Monoclonal Antibodies Revenue 2017-2028 (US$ Million)
    Figure 17. Global Monoclonal Antibodies Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 18. Global Monoclonal Antibodies Sales Market Share by Region (2017-2022)
    Figure 19. Global Monoclonal Antibodies Sales Market Share by Region (2023-2028)
    Figure 20. North America Monoclonal Antibodies Sales YoY (2017-2028) & (Kg)
    Figure 21. North America Monoclonal Antibodies Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Monoclonal Antibodies Sales YoY (2017-2028) & (Kg)
    Figure 23. Europe Monoclonal Antibodies Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Asia-Pacific Monoclonal Antibodies Sales YoY (2017-2028) & (Kg)
    Figure 25. Asia-Pacific Monoclonal Antibodies Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Latin America Monoclonal Antibodies Sales YoY (2017-2028) & (Kg)
    Figure 27. Latin America Monoclonal Antibodies Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Middle East & Africa Monoclonal Antibodies Sales YoY (2017-2028) & (Kg)
    Figure 29. Middle East & Africa Monoclonal Antibodies Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. The Monoclonal Antibodies Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 31. The Top 5 and 10 Largest Manufacturers of Monoclonal Antibodies in the World: Market Share by Monoclonal Antibodies Revenue in 2021
    Figure 32. Global Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 33. Global Monoclonal Antibodies Sales Market Share by Type (2017-2028)
    Figure 34. Global Monoclonal Antibodies Revenue Market Share by Type (2017-2028)
    Figure 35. Global Monoclonal Antibodies Sales Market Share by Application (2017-2028)
    Figure 36. Global Monoclonal Antibodies Revenue Market Share by Application (2017-2028)
    Figure 37. North America Monoclonal Antibodies Sales Market Share by Type (2017-2028)
    Figure 38. North America Monoclonal Antibodies Revenue Market Share by Type (2017-2028)
    Figure 39. North America Monoclonal Antibodies Sales Market Share by Application (2017-2028)
    Figure 40. North America Monoclonal Antibodies Revenue Market Share by Application (2017-2028)
    Figure 41. North America Monoclonal Antibodies Sales Share by Country (2017-2028)
    Figure 42. North America Monoclonal Antibodies Revenue Share by Country (2017-2028)
    Figure 43. U.S. Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
    Figure 44. Canada Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
    Figure 45. Europe Monoclonal Antibodies Sales Market Share by Type (2017-2028)
    Figure 46. Europe Monoclonal Antibodies Revenue Market Share by Type (2017-2028)
    Figure 47. Europe Monoclonal Antibodies Sales Market Share by Application (2017-2028)
    Figure 48. Europe Monoclonal Antibodies Revenue Market Share by Application (2017-2028)
    Figure 49. Europe Monoclonal Antibodies Sales Share by Country (2017-2028)
    Figure 50. Europe Monoclonal Antibodies Revenue Share by Country (2017-2028)
    Figure 51. Germany Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
    Figure 52. France Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
    Figure 53. U.K. Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
    Figure 54. Italy Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
    Figure 55. Russia Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
    Figure 56. Asia Pacific Monoclonal Antibodies Sales Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Monoclonal Antibodies Revenue Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Monoclonal Antibodies Sales Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Monoclonal Antibodies Revenue Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Monoclonal Antibodies Sales Share by Region (2017-2028)
    Figure 61. Asia Pacific Monoclonal Antibodies Revenue Share by Region (2017-2028)
    Figure 62. China Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
    Figure 63. Japan Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
    Figure 64. South Korea Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
    Figure 65. India Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
    Figure 66. Australia Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
    Figure 67. Taiwan Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
    Figure 68. Indonesia Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
    Figure 69. Thailand Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
    Figure 70. Malaysia Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
    Figure 71. Philippines Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
    Figure 72. Latin America Monoclonal Antibodies Sales Market Share by Type (2017-2028)
    Figure 73. Latin America Monoclonal Antibodies Revenue Market Share by Type (2017-2028)
    Figure 74. Latin America Monoclonal Antibodies Sales Market Share by Application (2017-2028)
    Figure 75. Latin America Monoclonal Antibodies Revenue Market Share by Application (2017-2028)
    Figure 76. Latin America Monoclonal Antibodies Sales Share by Country (2017-2028)
    Figure 77. Latin America Monoclonal Antibodies Revenue Share by Country (2017-2028)
    Figure 78. Mexico Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
    Figure 79. Brazil Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
    Figure 80. Argentina Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
    Figure 81. Middle East and Africa Monoclonal Antibodies Sales Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Monoclonal Antibodies Revenue Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Monoclonal Antibodies Sales Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Monoclonal Antibodies Revenue Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Monoclonal Antibodies Sales Share by Country (2017-2028)
    Figure 86. Middle East and Africa Monoclonal Antibodies Revenue Share by Country (2017-2028)
    Figure 87. Turkey Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
    Figure 88. Saudi Arabia Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
    Figure 89. U.A.E Monoclonal Antibodies Revenue (2017-2028) & (US$ Million)
    Figure 90. Monoclonal Antibodies Value Chain
    Figure 91. Monoclonal Antibodies Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed